Information  X 
Enter a valid email address

JPMorgan Chase & Co (80GT)

  Print   

Friday 14 January, 2022

JPMorgan Chase & Co

Form 8-K January 14, 2022 (4Q2021 presentation)

RNS Number : 5413Y
JPMorgan Chase & Co
14 January 2022
 

Regulatory Announcement

JPMorgan Chase & Co.

January 14, 2022

JPMorgan Chase & Co. has submitted the following document for posting on the website of Euronext Dublin and to the National Storage Mechanism of the UK Financial Conduct Authority:

• Current Report on Form 8-K of JPMorgan Chase & Co. dated January 14, 2022 containing the slides furnished for an investor presentation held on January 14, , 2022 to review JPMorgan Chase & Co.'s 2021 fourth quarter earnings, as furnished to the U.S. Securities and Exchange Commission

 

This document may also be viewed on the U.S. Securities and Exchange Commission's website ( www.sec.gov ) and on JPMorgan Chase & Co.'s investor relations website (https://jpmorganchaseco.gcs-web.com/ir/sec-other-filings/overview).

For further information, please contact:

John H. Tribolati

Corporate Secretary

JPMorgan Chase & Co.

Telephone number: +001 212 270 6000

Fax number: +001 212 270 4240

Email: [email protected]

DISCLAIMER -- INTENDED ADDRESSEES

Please note that the information contained in the above mentioned document(s) may be addressed to and/or targeted at persons who are residents of particular countries (specified in such document(s)) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom such document(s) is not addressed. Prior to relying on the information contained in such document(s) you must ascertain from the document(s) whether or not you are part of the intended addressees of the information contained therein. 

Your right to access this service is conditional upon complying with the above requirement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKZGMMVDKGZZM

a d v e r t i s e m e n t